The overarching goal of this concept is to encourage research that aims to better understand the real-world effectiveness of rapid-acting psychotropic interventional drugs (RAPIDs) in heterogenous patient populations and generate the actionable evidence needed by healthcare systems to guide broad clinical implementation.
Source: nimh